Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-16Clinical Trial Update: Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients [NA]
This update reports on a completed study evaluating how exercise affects blood lactate levels in Parkinson's disease and multiple sclerosis …
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Vercise Implantable Stimulator for Treating Parkinson's Disease [Phase 2]
Phase 2 trial results for the Vercise implantable stimulator in Parkinson's disease have been completed and posted.
-
CLINICAL_TRIALS withdrawal · 2015-11-13Clinical Trial Update: Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease [NA]
The clinical trial evaluating acamprosate for compulsive behaviors and craving in Parkinson's disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: Training Based On Declarative Memory Cues Improved Gait In Patients With Parkinson's Disease [NA]
A completed clinical study reported that gait in Parkinson disease patients improved when training was based on declarative memory cues.
-
FDA approval · 2015-11-05FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' supplemental application for a generic carbidopa-levodopa product. This expands access to treatment f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-11-05FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for Carbidopa and Levodopa from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2015-11-05FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for Carbidopa and Levodopa from Dr. Reddy's Laboratories Inc. This marks approval of a supplemental …
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia [Phase 3]
Phase 3 trial evaluating safety, tolerability, and efficacy of donepezil in Parkinson's disease patients with dementia; study completed.
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations [Phase 3]
This entry reports the completion of a Phase 3 trial evaluating E2007 in levodopa-treated Parkinson's disease patients with motor fluctuatio…
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide [Phase 1]
Phase 1 trial assessing pharmacokinetic and pharmacodynamic interactions between three single doses of BIA 9-1067 and a single dose of contr…
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease [Phase 1]
A Phase 1 study comparing the adhesiveness of two rotigotine transdermal patches for Parkinson's disease has completed. Results were posted …
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Dual Task Practice in Parkinson's Disease [Phase 3]
KU Leuven-sponsored Phase 3 clinical trial evaluating dual-task practice in Parkinson's disease has completed.
-
CLINICAL_TRIALS research · 2015-10-28Clinical Trial Update: Study on the Relationship Between Environmental and Occupational Exposure to Metals and Parkinson's Disease
A clinical trial update describing a study on whether environmental and occupational exposure to metals is related to Parkinson disease. The…
-
FDA approval · 2015-10-26FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals Inc)
FDA approved a supplemental application for Pramipexole dihydrochloride from ScieGen Pharmaceuticals Inc, confirming approval of a generic p…
-
CLINICAL_TRIALS research · 2015-10-22Clinical Trial Update: Neurogenic Overactive Bladder Treatment on Parkinson's Disease Through Back Tibial Nerve Electrostimulation [EARLY_Phase 1]
Early-phase clinical trial update on using back tibial nerve electrostimulation to treat neurogenic overactive bladder in Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease [Phase 1]
This Phase 1 study evaluates the pharmacokinetics and safety of LY03003 in patients with early-stage Parkinson's disease; the trial has comp…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease [NA]
This completed clinical trial compared pramipexole with levodopa in early Parkinson's disease and posted results on metabolic network activi…
-
FDA approval · 2015-10-19FDA Approved: ROPINIROLE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for ropinirole from Bionpharma Inc.
-
FDA approval · 2015-10-19FDA Approved: ROPINIROLE — Supplemental Application (Marlex Pharmaceuticals Inc)
The FDA approved a supplemental application for ropinirole submitted by Marlex Pharmaceuticals Inc. This action authorizes changes to an alr…
-
FDA approval · 2015-10-19FDA Approved: ROPINIROLE — Supplemental Application (Dr. Reddys Laboratories Limited)
FDA approved a supplemental application for ropinirole submitted by Dr. Reddys Laboratories Limited under ANDA 201576.
-
CLINICAL_TRIALS research · 2015-10-19Clinical Trial Update: Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia
An update on a clinical trial investigating common noradrenergic mechanisms in Parkinson's disease and L-DOPA-induced dyskinesia. The sponso…
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Study of the Effect of the Cognitive Orientation to Daily Occupational Performance (CO-OP) on Cognitive Impairment in Parkinson's Disease [NA]
A completed clinical trial evaluated the CO-OP cognitive intervention for cognitive impairment in Parkinson's disease.
-
FDA approval · 2015-10-16FDA Approved: ENTACAPONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ENTACAPONE submitted by Sun Pharmaceutical Industries, Inc. The action updates the product’s…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Pioglitazone in Early Parkinson's Disease [Phase 2]
Phase 2 trial of pioglitazone in early Parkinson's disease completed; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients [Phase 2]
Phase 2 safety and efficacy study of NH004 Films for relief of sialorrhea in Parkinson's disease patients completed; results posted in 2015.